News Mediacom

A partnership to develop a new tool for brain research

© dierk schaefer

29.10.12 - One Mind for Research and Guardian Angels For Smarter Life (GA) announced an alliance to design a new tool for the treatment of major brain diseases: micro devices that use nanotechnology monitor and transmit biological signals.

One Mind for Research, an independent non-profit organization dedicated to curing the diseases of the brain, and Guardian Angels For Smarter Life (GA), based at EPFL, have announced an alliance to design research projects in North America using the revolutionary GA Zero Power Biosensor and its potential for analysis, monitoring and treatment of major brain diseases. This strategic partnership will be a "Demonstrator" platform in GA’s bid for a €1Billion funding grant from the European Union “Future and Emerging Technologies” (FET).

Swiss-based GA is developing the Zero Power Biosensor, using low power nanoelectronics and nano/microsystems that harvest power rather than requiring batteries or power sources. Potential uses include monitoring of health status, monitoring ambient conditions for environmental danger, and, ultimately to perceive emotional conditions and provide functional activity.

“Our platform will create the ultimate smart device that will assist us from infancy to old age,” said Prof. Adrian Ionescu, co-project leader, Ecole Polytechnique Fédérale de Lausanne (EPFL). “One of the key features is its zero power requirement as it will scavenge for energy – think of it as recharging using the environment, sun or movement – a technology that will benefit from bio-inspired concepts.”

Individualized medicine

One Mind, with its mission to accelerate the development of treatments and cures for all major brain disorders, will ensure, through its healthcare-centric mission, the relevance of the Guardian Angels devices in real medical settings, organize field trials and provide necessary medical guidance and feedback.

Magali Haas, Chief Science and Technology Officer for One Mind, stated “The promise of individualized medicine for devastating brain diseases will be hastened through this unique interdisciplinary partnership. Together we will create next-generation technology to solve today’s real-world healthcare challenges.”

These autonomous, self-powered sensors, no larger than a band-aid, can uniquely record in a non-invasive way biological and environmental signals and transmit them automatically. The continuously collected complex medical and environmental data by arrays of sensors embedded in small, lightweight, wearable devices can serve as a data pipeline to drive mobile health technologies, medical decision support systems, disease modeling and other advances in healthcare that have never been possible before or ever even conceptualized.

  • Author:
  • One Mind/Swissnex Boston/EPFL
  • Source:
  • Mediacom
Return to previous page
Alumni
Olivier Glauser
Diplôme
Master en Informatique et systèmes de communication 1994
Parcours
1994 - 1996 HP
1996 - 1998 Phillippe Moris
1998 - 2005 MBA Universite de Harvard
2005 - 2009 ROTH Cl Partners
Fonction
Directeur général de Streamboat Ventures, Pékin

Contacts

Olivier Gauser
Steamboat Ventures
222 Hu Bin Road, Shanghai 200021
Tel: 86 (21) 2308 1800
olivier.glauser@steamboatvc.com
A3 EPFL
Rolex Learning Center
Case postale 122
1015 Lausanne 15
Tel: +41 (0)21 693 24 91